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Background
Host cells have developed a broad range of mechanisms
to counteract retroviral infection. Besides Trim5a (tri-
partite motif-containing protein 5alpha) and Tetherin,
APOBEC3 proteins (apolipoprotein B mRNA editing
enzyme catalytic polypeptide-like 3), especially APO-
BEC3G and APOBEC3F, are major factors in the post
entry inhibition of retroviruses. These proteins are
incorporated into budding virions and exhibit inhibitory
activity by interfering with reverse transcription and/or
by deamination of cytosine to uracil in the proviral
minus strand, resulting in hypermutation of the viral
DNA.
Mouse mammary tumor virus, MMTV, is a murine
pathogen causing mammary adenocarcinomas and T-
cell lymphomas in infected animals. The betaretrovirus,
which is transmitted from mother to pubs via milk,
infects dendritic cells, T-cells, B-cells and mammary
epithelial cells (MEC).
Previous studies showed that MMTV is inhibited by
mouse APOBEC3 and human APOBEC3G proteins.
However, the virus is also known to replicate in cells
expressing APOBEC3 proteins, suggesting a partial resis-
tance to the APOBEC-mediated antiviral effect.
Therefore, we sought to analyse the anti-MMTV activ-
ity of APOBEC3 proteins derived from various species
and compare it to the antiviral activity imposed on ΔVif
HIV-1.
Material and methods
MMTV- and HIV-1-based infectious particles were pre-
pared by co-transfection of 293T cells with an MMTV-
or HIV-1-based indicator construct carrying GFP,
together with a plasmid expressing MMTVor HIV-1
Gag and Pol proteins, a vector expressing the VSV-G
protein and finally with varied amounts of APOBEC3-
expressing plasmids. The antiviral activity of APOBEC3
proteins was determined by measuring the reduction of
GFP-positive target cells in the presence of APOBEC3.
Results
We found MMTV to be approximately 10-fold more
resistant to murine APOBEC3Δex5 and human APO-
BEC3G proteins than ΔVif HIV-1. Furthermore, other
APOBEC3 proteins such as APOBEC3G from rhesus
macaque and hAPOBEC3F showed only moderate effect
on MMTV.
The mechanism responsible for the partial resistance
to APOBEC3 proteins is currently unknown. Because
we were able to detect the mAPOBEC3 and hAPOBEC3
in virions, a mechanism which involves exclusion of
APOBEC3 from virus particles seems unlikely.
Additionally, we investigated the antiviral activity of
novel splice variants of mAPOBEC3 identified from
PBMCs of C57/BL6 mice. We found these variants to
show low activity against both MMTV and ΔVif HIV-1.
Conclusions
Taken together, our data suggest that MMTV is partially
resistant to the antiviral effects of APOBEC3 proteins.
We found that expression of APOBEC3G from rhesus
macaque or hAPOBEC3F have only moderate effect on
MMTV. Furthermore, we observed that MMTV is
inhibited by mAPOBEC3Δex5 and hAPOBEC3G, but
the extent of inhibition is significantly lower than that
detected with ΔVif HIV-1.
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